Přehled o publikaci
2025
Reference genomic database of the Czech population
SVOZILOVÁ, Hana; Karla PLEVOVÁ; Simone Andrea BIAGINI; Jakub Paweł PORC; Jakub HYNŠT et al.Basic information
Original name
Reference genomic database of the Czech population
Authors
SVOZILOVÁ, Hana; Karla PLEVOVÁ; Simone Andrea BIAGINI; Jakub Paweł PORC; Jakub HYNŠT; Jan SVATOŇ; Boris TICHÝ; Vojtěch BYSTRÝ; Viktor STRANECKY; Katerina JIRSOVA; Hana HARTMANNOVA; Michaela BENDOVA; Josef SROVNAL; Jiri DRABEK; Zuzana ROZANKOVA; Marta KALOUSOVA; Tomas ZIMA; Jana VACULÍKOVÁ; Terézia KURUCOVÁ; Jarmila SIMOVA; Lukáš HEJTMÁNEK; Michael DOUBEK; Vera FRANKOVA; Lucie BENESOVA; Magdalena UVIROVA; Stanislav KMOCH; Milan MACEK; Marian HAJDUCH and Šárka POSPÍŠILOVÁ
Edition
European Human Genetics Conference, Milan, 2025
Other information
Language
English
Type of outcome
Konferenční abstrakta
Country of publisher
Italy
Confidentiality degree
is not subject to a state or trade secret
References:
Marked to be transferred to RIV
No
Organization
Lékařská fakulta – Repository – Repository
Keywords in English
Czech; WGS; reference
Links
EH22_008/0004593, research and development project.
Changed: 15/2/2026 00:51, RNDr. Daniel Jakubík
Abstract
In the original language
gt;0.0884) were removed, retaining onlythird-degree or more distant relatives. Population genetic analyses, including principal component analysis (PCA), were conducted to exploredemographic patterns. Data were compared with global datasets, such as the 1000 Genomes Project (1KGP). Results: The A-C-G-T database(database.acgt.cz) contains WGS data from 1,257 healthy individuals (611 females, 646 males) after removing 10 technical outliers and 23samples with cryptic relatedness from the initial dataset (N=1,290). In the PCA, the samples cluster with other European groups from the1KGP, forming a distinct group that is well-separated from other clusters of European populations. An internal analysis revealed a possiblegenetic cline across the country. Conclusion: This Czech-specific reference improves local variant interpretation and supports precisionmedicine in Central Europe. A follow-up project (A-C-G-T 2) will expand on these data by further exploring genome variation in A-C-G-Tparticipants and analyzing patient cohorts.